Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute for Clinical Genetics, |
RCV001771699 | SCV002011548 | uncertain significance | Fanconi anemia complementation group I | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001885118 | SCV002165943 | uncertain significance | Fanconi anemia | 2022-08-09 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 425 of the FANCI protein (p.Ile425Val). This variant is present in population databases (rs775228768, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with FANCI-related conditions. ClinVar contains an entry for this variant (Variation ID: 1319718). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Sema4, |
RCV001885118 | SCV002536489 | uncertain significance | Fanconi anemia | 2022-03-18 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV001771699 | SCV002792875 | uncertain significance | Fanconi anemia complementation group I | 2021-07-27 | criteria provided, single submitter | clinical testing |